A 2014 study found that India’s National Vector Borne Disease Control Programme captures only 0.35% of the annual number of clinically diagnosed dengue cases.
A total of 632 people died due to influenza (H1N1), while Aedes Aegypti (AES) and Japanese Encephalitis (JE) claimed 279 and 60 lives respectively.
Zeroing in on the genesis of the Kyasanur forest disease was, at one point, called “possibly the most dramatic epidemiological detective story of our time.” This is that story.
New York City’s health department has invested in novel products and technologies to combat Aedes and arrest its rapid spread in densely populated urban areas.
A large number of chikungunya cases have occurred due to heavy rainfall in many parts of the country, especially in Delhi, posing a serious health threat.
Zika viruses have been found in tears, possibly explaining why some patients have suffered from conjunctivitis and, in rare cases, permanent vision loss.
With grave repercussions for India, a recent study suggests that the Zika virus can be even more infectious to people who have been exposed to dengue in their past.
The WHO maintains that canceling the Olympics, or relocating the games, is not going to alter the international spread of Zika. In a world connected by travel and migration, opportunities for the virus to cross borders extend far beyond sporting events.
We know a lot more about the origins of the ongoing Zika virus outbreak, the nature of the virus strain and its link with brain disorders today than we did last month.
Given that mosquito-borne diseases are amongst the biggest killers on Earth today, going for a complete eradication is never out of health officials’ minds.
The Zika virus has considerable potential to penetrate our borders to play havoc amid the ideal conditions provided both for it and the mosquitoes.
India is one of the Aedes aegyptis’s many homes but the Zika virus itself has not ever been detected in our country so far.
As India embarks on its biggest urban expansion yet, dengue prevention at construction sites must become an urgent priority in the years ahead.
We are sitting ducks against a virus that has no antidote as yet and which can take out both children and adults.
Amidst the seemingly losing battle against the virus, recent research has kindled hopes over ‘designer antibodies’ engineered to elicit the immune response needed to beat the virus